戻る
Unicycive Therapeutics Inc (UNCY)価格
UNCY 株価推移チャート
UNCY 収入
Unicycive Therapeutics Inc
$6.19
-1.27%
$-0.07
終値： Jan 16, 16:00:00 GMT-5
$6.18
-0.16%
$-0.01
プレマーケット： Jan 20, 07:59:06 GMT-5
主要データ
前終値
$6.27
始値
$6.27
当日レンジ
$6.01 - $6.3
52週レンジ
$3.71 - $11
取引高
582.3K
平均取引高
436.7K
1株当たり利益(TTM)
-2.01
配当利回り
--
時価総額
$132.8M
UNCYとは何ですか？
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. The company is headquartered in Los Altos, California and currently employs 22 full-time employees. The company went IPO on 2021-06-17. The firm's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.